14 Apr. 2016
WILMINGTON, N.C., (April 14, 2016) – Pharmaceutical Product Development, LLC (PPD) today announced it has appointed Panteli Theocharous, FIBMS, Ph.D., FRCPath, as vice president of global product development in the hematology/oncology therapeutic area.
"Panteli brings extensive expertise in hematology and oncology and biopharmaceutical R&D to PPD’s global product development team,” said Rob Dow, senior vice president of medical affairs for PPD. “Panteli is a recognized thought leader in oncology, and throughout his career he has worked on marketing authorization applications, lifecycle management and pricing and reimbursement negotiations for more than 20 hematology and oncology molecules.”
Hematology and oncology form one of PPD’s leading therapeutic areas, with more than 400 studies with clinical components conducted in this area in the past five years. PPD’s commitment to hematology and oncology drug development is evidenced by the company’s clinical support of 40 percent of the new drug applications (NDA) and supplemental new drug applications (sNDA) approvals over the past three years.
Theocharous most recently served as vice president and head of clinical and medical affairs at Cell Therapeutics, Inc., Life Sciences in London. Previously, he was with Johnson & Johnson, where he held leadership positions in global medical affairs, clinical development and regulatory affairs for the company’s hematology/oncology research and development programs.
Theocharous earned a bachelor’s degree in medical biochemistry from King’s College, University of London; a master’s degree in applied clinical hematology from the University of Westminster; and higher degrees in medicine, specializing in hematological oncology, from the Royal Free and University College Medical School at the University of London, where he later was a director of stem cell transplantation and cellular therapeutics. He serves as an honorary patron and medical expert for the Leukaemia Cancer Society.
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and more than 15,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development to deliver life-changing therapies that improve health.
+1 910 558 6096
+1 910 558 6783